Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution

被引:13
|
作者
Tian, Li [1 ,2 ]
Wu, Jin [3 ]
Fu, Mingde [1 ,2 ]
Xu, Yanhua [4 ]
Jia, Lianqun [1 ,2 ]
机构
[1] Sichuan Univ, W China Hosp, Lab Endocrinol & Metab, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, W China Hosp 4, Chengdu 610041, Sichuan, Peoples R China
[4] Chengdu Hoist Biotechnol Co LTD, Chengdu 610041, Sichuan, Peoples R China
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2009年 / 58卷 / 05期
关键词
PLASMA-LIPOPROTEINS; HDL SUBCLASSES; A-I; CHOLESTEROL ACYLTRANSFERASE; TRIGLYCERIDE-RICH; LIPASE MASS; METABOLISM; PROTEIN; APOPROTEIN; RISK;
D O I
10.1016/j.metabol.2009.01.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High-density lipoprotein (HDL) Subclasses have different antiatherogenic potentials and functional properties. This work presents our findings and discussions on their metabolic implications on apolipoprotein (apo) C-III together with other apolipoprotein levels and HDL subclass distribution profile. Apolipoprotein A-I contents of plasma HDL Subclasses were quantitated by 2-dimensional gel electrophoresis coupled with immunodetection in 511 subjects. Concentrations of triglycerides and of apo B-100, C-II, and C-III were higher, whereas those of HDL cholesterol were lower, for subjects in the highest tertile of apo C-III levels group, which presented a typical hypertriglyceridemic lipid profile. Subjects in the middle and highest tertile of apo C-III levels groups had increased pre beta(1)-HDL, HDL3c, HDL3b (only in the highest tertile of apo C-III group), and HDL3a, but decreased HDL2a and HDL2b contents compared with subjects in the lowest tertile of apo C-III levels group. With the elevation of apo C-III together with apo C-II levels, contents of small-sized pre beta(1)-HDL increased successively and significantly; but those of large-sized HDL2b reduced successively and significantly. With a rise in apo C-III and apo A-1 levels, those of pre beta(1)-HDL increased significantly. Moreover, Subjects with high apo A-1 levels showed a Substantial increase in HDL2b; on the contrary, HDL2b declined progressively and obviously for subjects in the low apo A-I levels with the elevation of apo C-III levels. Correlation analysis illustrated that apo C-III levels were positively associated with pre beta(1)-HDL, pre beta(2)-HDL, and HDL3a. The particle size of HDL shifted toward smaller sizes with the increase of plasma apo C-III levels, and the shift was more remarkable when the elevation of apo C-III and apo C-II was simultaneous; and besides, higher apo A-1 concentrations could modify the effect of apo C-III on HDL Subclass distribution profile. Large-sized HDL2b particles decreased greatly for hypertriglyceridemic subjects who were characterized by elevated apo C-III and C-II accompanied with significantly lower apo A-I, which, in turn, blocked the maturation of HDL. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:668 / 674
页数:7
相关论文
共 50 条
  • [1] Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk
    Aroner, Sarah A.
    Yang, Ming
    Li, Junlong
    Furtado, Jeremy D.
    Sacks, Frank M.
    Tjonneland, Anne
    Overvad, Kim
    Cai, Tianxi
    Jensen, Majken K.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2017, 186 (06) : 736 - 744
  • [2] The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations
    Tian, L.
    Fu, M.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (06) : 461 - 472
  • [3] The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations
    L. Tian
    M. Fu
    [J]. Journal of Endocrinological Investigation, 2011, 34 : 461 - 472
  • [4] INDEPENDENT REGULATION OF APOLIPOPROTEIN C-III AND C-II ON VERY LOW AND HIGH-DENSITY LIPOPROTEINS - POSSIBLE ROLE OF APOLIPOPROTEIN C-III IN LIPOPROTEIN METABOLISM
    LE, NA
    GINSBERG, HN
    [J]. CLINICAL RESEARCH, 1985, 33 (02): : A435 - A435
  • [5] Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks
    Onat, A.
    Hergenc, G.
    Ayhan, E.
    Ugur, M.
    Kaya, H.
    Tuncer, M.
    Can, G.
    [J]. DIABETIC MEDICINE, 2009, 26 (10) : 981 - 988
  • [6] Increased serum concentration of apolipoprotein C-III and its greater distribution to chylomicrons than to the high-density lipoprotein fraction in a calf with hyperlipidemia
    Yamamoto, M
    Oohashi, T
    Katoh, N
    Oikawa, S
    [J]. JOURNAL OF VETERINARY MEDICAL SCIENCE, 2000, 62 (10): : 1033 - 1039
  • [7] Plasma apolipoprotein C-III transport in centrally obese men: Associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism
    Chan, Dick C.
    Nguyen, Minh N.
    Watts, Gerald F.
    Barrett, P. Hugh R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (02): : 557 - 564
  • [8] AN ANTISENSE INHIBITOR OF APOLIPOPROTEIN C-III SIGNIFICANTLY DECREASES APOLIPOPROTEIN C-III, TRIGLYCERIDES, VERY-LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND PARTICLE NUMBER, AND INCREASES HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND PARTICLE NUMBER IN HYPERTRIGLYCERIDEMIC PATIENTS ON A FIBRATE
    Alexander, Vickie
    Gaudet, Daniel
    Cheng, Wei
    Flaim, Joann
    Hughes, Steve
    Singleton, Walter
    Geary, Richard
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1453 - A1453
  • [9] High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts
    Jensen, Majken K.
    Aroner, Sarah A.
    Mukamal, Kenneth J.
    Furtado, Jeremy D.
    Post, Wendy S.
    Tsai, Michael Y.
    Tjonneland, Anne
    Polak, Joseph F.
    Rimm, Eric B.
    Overvad, Kim
    McClelland, Robyn L.
    Sacks, Frank M.
    [J]. CIRCULATION, 2018, 137 (13) : 1364 - +
  • [10] The relationship between high density lipoprotein subclass profile and plasma lipids concentrations
    Tian, Li
    Fu, Mingde
    [J]. LIPIDS IN HEALTH AND DISEASE, 2010, 9